European Respiratory Society Statement on Long COVID-19 Follow-Up.

Antoniou, Katerina M; Vasarmidi, Eirini; Russell, Anne-Marie; Andrejak, Claire; Crestani, Bruno; Delcroix, Marion; Dinh-Xuan, Anh Tuan; Poletti, Venerino; Sverzellati, Nicola; Vitacca, Michele; Witzenrath, Martin; Tonia, Thomy; Spanevello, Antonio (2022). European Respiratory Society Statement on Long COVID-19 Follow-Up. European respiratory journal, 60(2), p. 2102174. European Respiratory Society 10.1183/13993003.02174-2021

Preview

Text Antoniou_EurRespirJ_2022.pdf - Published Version Available under License Creative Commons: Attribution-Noncommercial (CC-BY-NC). Download (750kB) | Preview

Patients diagnosed with COVID-19 associated with SARS-CoV-2 infection frequently experience symptom burden post-acute infection or post-hospitalisation. We aim to identify optimal strategies for follow-up care that may positively impact the patient's quality-of-life (QOL).A European Respiratory Society (ERS) Task Force (TF) convened and prioritised eight clinical questions. A targeted search of the literature defined the time line of long COVID-19 as one to six months post infection and identified clinical evidence in the follow-up of patients. Studies meeting the inclusion criteria report an association of characteristics of acute infection with persistent symptoms, thromboembolic events in the follow-up period and evaluations of pulmonary physiology and imaging. Importantly, this statement reviews QOL consequences, symptom burden, disability and home care follow-up. Overall, the evidence for follow-up care for patients with long COVID-19 is limited.

Interest & Impact

Downloads

20 since deposited on 18 Feb 2022
20 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item